Scanogen

Scanogen is a biotechnology company focused on developing next-generation molecular diagnostic platforms for the rapid detection of infectious diseases. The company's core technology, Single-Molecule Scanning (SMS), enables the direct detection of DNA and RNA molecules without the need for traditional amplification methods like PCR. This approach significantly reduces turnaround time and complexity while maintaining high sensitivity and specificity. Scanogen's primary clinical focus is on critical conditions such as sepsis and respiratory infections, aiming to provide laboratory-quality results at the point of care. By streamlining the diagnostic workflow, the company seeks to improve patient outcomes through faster targeted therapy.